Id |
Subject |
Object |
Predicate |
Lexical cue |
TextSentencer_T1 |
0-127 |
Sentence |
denotes |
MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. |
T1 |
0-127 |
Sentence |
denotes |
MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. |
TextSentencer_T2 |
128-317 |
Sentence |
denotes |
The novel mitogen/extracellular-signal-regulated kinase kinase 5/extracellular signal-regulated kinase-5 (MEK5/ERK5) pathway has been implicated in the regulation of cellular proliferation. |
T2 |
128-317 |
Sentence |
denotes |
The novel mitogen/extracellular-signal-regulated kinase kinase 5/extracellular signal-regulated kinase-5 (MEK5/ERK5) pathway has been implicated in the regulation of cellular proliferation. |
TextSentencer_T3 |
318-474 |
Sentence |
denotes |
MEK5 expression has been detected in prostate cancer cells, although the significance of the MEK5/ERK5 pathway in human prostate cancer has not been tested. |
T3 |
318-474 |
Sentence |
denotes |
MEK5 expression has been detected in prostate cancer cells, although the significance of the MEK5/ERK5 pathway in human prostate cancer has not been tested. |
TextSentencer_T4 |
475-658 |
Sentence |
denotes |
We examined MEK5 expression in 127 cases of prostate cancer and 20 cases of benign prostatic hypertrophy (BPH) by immunohistochemistry and compared the results to clinical parameters. |
T4 |
475-658 |
Sentence |
denotes |
We examined MEK5 expression in 127 cases of prostate cancer and 20 cases of benign prostatic hypertrophy (BPH) by immunohistochemistry and compared the results to clinical parameters. |
TextSentencer_T5 |
659-767 |
Sentence |
denotes |
We demonstrated that MEK5 expression is increased in prostate cancer as compared to benign prostatic tissue. |
T5 |
659-767 |
Sentence |
denotes |
We demonstrated that MEK5 expression is increased in prostate cancer as compared to benign prostatic tissue. |
TextSentencer_T6 |
768-885 |
Sentence |
denotes |
Strong MEK5 expression correlates with the presence of bony metastases and less favourable disease-specific survival. |
T6 |
768-885 |
Sentence |
denotes |
Strong MEK5 expression correlates with the presence of bony metastases and less favourable disease-specific survival. |
TextSentencer_T7 |
886-1018 |
Sentence |
denotes |
Furthermore, among the patients with high Gleason score of 8-10, MEK5 overexpression has an additional prognostic value in survival. |
T7 |
886-1018 |
Sentence |
denotes |
Furthermore, among the patients with high Gleason score of 8-10, MEK5 overexpression has an additional prognostic value in survival. |
TextSentencer_T8 |
1019-1180 |
Sentence |
denotes |
MEK5 transfection experiments confirm its ability to induce proliferation (P < 0.0001), motility (P = 0.0001) and invasion in prostate cancer cells (P = 0.0001). |
T8 |
1019-1180 |
Sentence |
denotes |
MEK5 transfection experiments confirm its ability to induce proliferation (P < 0.0001), motility (P = 0.0001) and invasion in prostate cancer cells (P = 0.0001). |
TextSentencer_T9 |
1181-1256 |
Sentence |
denotes |
MEK5 expression drastically increased MMP-9, but not MMP-2 mRNA expression. |
T9 |
1181-1256 |
Sentence |
denotes |
MEK5 expression drastically increased MMP-9, but not MMP-2 mRNA expression. |
TextSentencer_T10 |
1257-1497 |
Sentence |
denotes |
Luciferase report assays suggest that the -670/MMP-9 promoter is upregulated by MEK5 and electromobility shift assay further suggests the involvement of activator protein-I (AP-1), but not the NF-kappa B, binding site in the MMP-9 promoter. |
T10 |
1257-1497 |
Sentence |
denotes |
Luciferase report assays suggest that the -670/MMP-9 promoter is upregulated by MEK5 and electromobility shift assay further suggests the involvement of activator protein-I (AP-1), but not the NF-kappa B, binding site in the MMP-9 promoter. |
TextSentencer_T11 |
1498-1608 |
Sentence |
denotes |
Using an AP-1 luciferase construct, activation of MEK5 was confirmed to enhance AP-1 activities up to twofold. |
T11 |
1498-1608 |
Sentence |
denotes |
Using an AP-1 luciferase construct, activation of MEK5 was confirmed to enhance AP-1 activities up to twofold. |
TextSentencer_T12 |
1609-1721 |
Sentence |
denotes |
Taken together, our results establish MEK5 as a key signalling molecule associated with prostate carcinogenesis. |
T12 |
1609-1721 |
Sentence |
denotes |
Taken together, our results establish MEK5 as a key signalling molecule associated with prostate carcinogenesis. |
TextSentencer_T13 |
1722-1815 |
Sentence |
denotes |
As the MEK5/ERK5 interaction is highly specific, it represents a potential target of therapy. |
T13 |
1722-1815 |
Sentence |
denotes |
As the MEK5/ERK5 interaction is highly specific, it represents a potential target of therapy. |